CHAFF
发表于 2025-3-21 16:28:31
书目名称Ovarian Cancer影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0705198<br><br> <br><br>书目名称Ovarian Cancer影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0705198<br><br> <br><br>书目名称Ovarian Cancer网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0705198<br><br> <br><br>书目名称Ovarian Cancer网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0705198<br><br> <br><br>书目名称Ovarian Cancer被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0705198<br><br> <br><br>书目名称Ovarian Cancer被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0705198<br><br> <br><br>书目名称Ovarian Cancer年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0705198<br><br> <br><br>书目名称Ovarian Cancer年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0705198<br><br> <br><br>书目名称Ovarian Cancer读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0705198<br><br> <br><br>书目名称Ovarian Cancer读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0705198<br><br> <br><br>
ABYSS
发表于 2025-3-21 21:12:47
http://reply.papertrans.cn/71/7052/705198/705198_2.png
同谋
发表于 2025-3-22 01:55:52
The human tumor clonogenic assay used to study ovarian cancers,47 showed that the addition of cisplatin to cyclophosphamide and doxorubicin improved response rates from 46% to 71% with the median duration of survival increasing from 9.5 months to 15.0 months . The fact, however, becomes apparent that a. survival duration of 15 months is not a cure, and the g
neutrophils
发表于 2025-3-22 04:53:01
http://reply.papertrans.cn/71/7052/705198/705198_4.png
郊外
发表于 2025-3-22 10:52:48
http://reply.papertrans.cn/71/7052/705198/705198_5.png
征兵
发表于 2025-3-22 13:02:33
0927-3042fashion. First, by di viding the oncology literature into specific subdivisions such as lung cancer, genitourinary cancer, pediatric oncology, etc. Second, by978-1-4612-9609-6978-1-4613-2561-1Series ISSN 0927-3042 Series E-ISSN 2509-8497
Musket
发表于 2025-3-22 18:02:57
Book 1985extbooks are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often preliminary reports on a very limited number of patients. Certain general journals fre quently publish good in-depth reviews of cancer topics, and published sym
扩张
发表于 2025-3-22 22:33:25
http://reply.papertrans.cn/71/7052/705198/705198_8.png
不法行为
发表于 2025-3-23 03:54:51
http://reply.papertrans.cn/71/7052/705198/705198_9.png
Fracture
发表于 2025-3-23 09:15:47
Multiagent chemotherapy in advanced ovarian carcinoma,e taken place. In fact, dealing with this tumor remains a frustrating experience to all cancer specialists. Advanced ovarian carcinoma (FIGO Stages III and IV) remains the most common gynecologic cancer killer with 18,200 estimated new cases and 11,500 estimated deaths in 1983 (6% of all female cancer deaths) .